Impact of Recreational Cannabis Legalization on Opioid Prescribing and Opioid-Related Hospital Visits in Colorado: an Observational Study.
Impact of Recreational Cannabis Legalization on Opioid Prescribing and Opioid-Related Hospital Visits in Colorado: an Observational Study.
复制标题
DOI:
10.1007/s11606-023-08195-3
复制
发表时间:
2023-09
影响因子:
5.7
通讯作者:
Pacula, Rosalie Liccardo
中科院分区:
文献类型:
--
作者:
Buttorff, Christine;Wang, George Sam;Wilks, Asa;Tung, Gregory;Kress, Amii;Schwam, Dan;Pacula, Rosalie Liccardo
Cannabis may be a substitute for opioids but previous studies have found conflicting results when using data from more recent years. Most studies have examined the relationship using state-level data, missing important sub-state variation in cannabis access. To examine cannabis legalization on opioid use at the county level, using Colorado as a case study. Colorado allowed recreational cannabis stores in January 2014. Local communities could decide whether to allow dispensaries, creating variation in the level of exposure to cannabis outlets. Observational, quasi-experimental design exploiting county-level variation in allowance of recreational dispensaries. Colorado residents We use licensing information from the Colorado Department of Revenue to measure county-level exposure to cannabis outlets. We use the state’s Prescription Drug Monitoring Program (2013–2018) to construct opioid-prescribing measures of number of 30-day fills and total morphine equivalents, both per county resident per quarter. We construct outcomes of opioid-related inpatient visits (2011–2018) and emergency department visits (2013–2018) with Colorado Hospital Association data. We use linear models in a differences-in-differences framework that accounts for the varying exposure to medical and recreational cannabis over time. There are 2048 county-quarter observations used in the analysis. We find mixed evidence of cannabis exposure on opioid-related outcomes at the county level. We find increasing exposure to recreational cannabis is associated with a statistically significant decrease in number of 30-day fills (coefficient: −117.6, p-value<0.01) and inpatient visits (coefficient: −0.8, p-value: 0.03), but not total MME nor ED visits. Counties with no medical exposure prior to recreational legalization experience greater reductions in the number of 30-day fills and MME than counties with prior medical exposure (p=0.02 for both). Our mixed findings suggest that further increases in cannabis beyond medical access may not always reduce opioid prescribing or opioid-related hospital visits at a population level.
登录
查看更多内容
影响因子:
39
作者:
Bachhuber, Marcus A.;Saloner, Brendan;Cunningham, Chinazo O.;Barry, Colleen L.
通讯作者:
Barry, Colleen L.
影响因子:
9.7
作者:
Bradford, Ashley C.;Bradford, W. David
通讯作者:
Bradford, W. David
影响因子:
4.4
作者:
Dilley, Julia A.;Hitchcock, Laura;Richardson, Susan M.
通讯作者:
Richardson, Susan M.
DOI:
10.1111/add.15228
发表时间:
2021-05
期刊:
Addiction (Abingdon, England)
影响因子:
--
作者:
Gorfinkel LR;Stohl M;Greenstein E;Aharonovich E;Olfson M;Hasin D
通讯作者:
Hasin D
影响因子:
12.7
作者:
Livingston, Melvin D.;Barnett, Tracey E.;Wagenaar, Alexander C.
通讯作者:
Wagenaar, Alexander C.